Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The RAATE-MCI proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. RAATE-MCI is a 52-week randomized controlled trial. 144 African American adults aged 60 and older will be recruited.
Full description
Regular physical activity has proven to be a safe and effective means to enhance cognitive function in older adults ranging from cognitively healthy to mildly cognitively impaired. A large body of existing data suggests that exercise improves cardiovascular and cerebrovascular functioning and thus has the potential to enhance perivascular clearance of amyloid and reduce chronic brain tissue ischemia, among other beneficial effects. Therefore, our study is focused on physical activity promotion, a potent approach to modifying multiple neurobiological pathways implicated in Alzheimer's Disease. RAATE-MCI is a 52-week randomized controlled trial that will assign insufficiently active African American adults aged 60 and older to one of two groups: a physical activity intervention or a successful aging (active control) group. Outcome measures will be collected at baseline, 24-,and 52-weeks. 144 older African American adults will be recruited.
Intervention will consist of one of two groups: a 150 minutes of physical activity (PA) per week or successful aging (SA) group. All physical activity and successful aging group sessions will be conducted at Pennington Biomedical or at local community facilities that include branches of the YMCA and community centers.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
have cognitive impairment that would interfere with participating in a group discussion
a. cognitive performance in the demented range (score < 3 SDs below the mean on NIH Toolbox scores for their age and sex on at least one of the subtests)
meet criteria for dementia
are unwilling to give written informed consent or accept randomization in either study group
are too active (as defined by ≥10 min bouts of MVPA as measured by Actigraph) if:
have uncontrolled hypertension (systolic blood pressure > 150 mmHg and/or diastolic blood pressure > 90 mmHg).
have had a myocardial infarction, major heart surgery (i.e., valve replacement or bypass surgery), stroke, deep vein thrombosis, pulmonary embolus, hip fracture, hip or knee replacement, or spinal surgery in the past 6 months
are undergoing cardiopulmonary rehabilitation
have uncontrolled diabetes that in the judgment of the MI may interfere with study participation
have clinically diagnosed osteoporosis that in the judgment of the MI may interfere with study participation
are currently enrolled in another randomized trial involving lifestyle or pharmaceutical interventions
have another member of the household that is a participant in RAATE or RAATE MCI
refuse to participate in the study without disclosure of their amyloid PET scan results
refuse to allow anonymized versions of their study data for research after this study is completed.
have other medical, psychiatric, or behavioral factors that in the judgment of the Principal or Medical Investigator may interfere with study participation or the ability to follow the intervention protocol
Primary purpose
Allocation
Interventional model
Masking
144 participants in 2 patient groups
Loading...
Central trial contact
Callie Hebert, MS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal